Crinetics Pharmaceuticals (CRNX) Reports Q4 Loss of $0.66/sh

Crinetics Pharmaceuticals (NASDAQ: CRNX) reported Q4 EPS of ($0.66), versus ($0.60) reported last year.

For earnings history and earnings-related data on Crinetics Pharmaceuticals (CRNX) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Intel (INTC) PT Lowered to $92 at Mizuho
• Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance